Trial Profile
Phase II/III STUDY Of ACP-01 for angina pectoris
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 29 Jan 2019
Price :
$35
*
At a glance
- Drugs ACP 01 (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 17 Jan 2019 According to a Hemostemix media release, the company expects to file an IND application with the FDA in Q1 2019.
- 20 Jul 2018 New trial record